Rapid Multi-Directed Cholinergic Transmission in the Central Nervous System

Santhosh Sethuramanujam,Akihiro Matsumoto,Geoff deRosenroll,Benjamin Murphy-Baum,Claudio Grosman,J. Michael McIntosh,Miao Jing,Yulong Li,David Berson,Keisuke Yonehara,Gautam B. Awatramani

DOI: https://doi.org/10.1038/s41467-021-22763-3

IF: 16.6

2021-01-01

Nature Communications

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-22763-3

What problem does this paper attempt to address?

Rapid ‘multi-directed’ cholinergic transmission at central synapses

Santhosh Sethuramanujam,Akihiro Matsumoto,J. Michael McIntosh,Miao Jing,Yulong Li,David Berson,Keisuke Yonehara,Gautam B. Awatramani

DOI: https://doi.org/10.1101/2020.04.18.048330

2020-01-01

bioRxiv

Abstract:Acetylcholine (ACh) is a key neurotransmitter that plays diverse roles in many parts of the central nervous system, including the retina. However, assessing the precise spatiotemporal dynamics of ACh is technically challenging and whether ACh transmits signals via rapid, point-to-point synaptic mechanisms, or broader-scale ‘non-synaptic’ mechanisms has been difficult to ascertain. Here, we examined the properties of cholinergic transmission at individual contacts made between direction-selective starburst amacrine cells and downstream ganglion cells in the retina. Using a combination of electrophysiology, serial block-face electron microscopy, and two-photon ACh imaging, we demonstrate that ACh signaling bears the hallmarks of both non-synaptic and synaptic forms of transmission. ACh co-activates nicotinic ACh receptors located on the intersecting dendrites of pairs of ganglion cells, with equal efficiency (non-synaptic)— and yet retains the ability to generate rapid ‘miniature’ currents (∼1 ms rise times: synaptic). Fast cholinergic signals do not appear to depend on anatomically well-defined synaptic structures. We estimate that ACh spread is limited to ∼1-2 m from its sites of release, which may help starbursts drive local direction-selective cholinergic responses in ganglion cell dendrites. Together, our results establish the functional architecture for cholinergic signaling at a central synapse and propose a novel motif whereby single presynaptic sites can co-transmit information to multiple neurons on a millisecond timescale.
A Cholinergic Model Synapse to Elucidate Protein Function at Presynatic Terminals

Huan Ma,Sumiko Mochida

DOI: https://doi.org/10.1016/j.neures.2006.12.015

IF: 2.904

2007-01-01

Neuroscience Research

Abstract:A large number of proteins have been identified at nerve terminals and a cascade of protein-protein interactions has been suggested to be involved in cycling of synaptic vesicle states. To explore protein function in presynaptic terminals, only a few unique synapses such as the squid giant synapse, the calyx of Held synapse and the hippocampal neuron autapse have been used. The squid giant synapse and the calyx of Held are useful to introduce reagents into their large presynaptic terminals and the hippocampal neuron autapse is a good system to modify a protein level by exogenous DNA or RNA. The cholinergic synapse formed between superior cervical ganglion (SCG) neurons in long-term culture is a useful model for a fast synapse. The axon of the large cell body contacts with soma of neighboring neurons. The architecture of synaptic connections makes it possible to introduce reagents into the presynaptic terminals by diffusion from a cell body within a short time. Introduction of exogenous cDNA or siRNA performed by microinjection into a SCG neuron allows us to modulate the level of the protein of interest or to express mutant proteins in the neuron. Here, we describe use of the model SCG neuronal synapse to elucidate function of presynaptic proteins in mediating synaptic transmission.
Multichannel Fiber-Based Simultaneous Neural Stimulation and Signal Readout in Vivo

Yue Zhu,Ke Si,Wei Gong

DOI: https://doi.org/10.1117/12.2651649

2022-01-01

Abstract:In order to overcome the depth limitation of light penetration in brain tissue, a promising approach in optogenetics is implanting multimode optical fibers for stimulation and fluorescence imaging. However, traditional fiber photometry can only realize stimulation or recording in a single brain region, so optogenetic stimulation and simultaneous recording at the implantation site cannot be achieved. And there is currently no scheme for synchronization of multiple brain regions, therefore the connection between brain regions cannot be strictly proved. To overcome these issues, we developed a multichannel fiber-based in vivo simultaneous neural stimulation and signal readout system. Different from traditional fiber photometry, our system uses the galvanometer scanning technology and a specially-made optical fiber bundle with 200-μm diameter to realize high-precision multichannel stimulation with up to 1-kHz frequency and simultaneous recording. Combined with the specific light-sensitive proteins such as ChrimsonR and genetically encoded calcium indicator GCamP6s, we realize simultaneous optogenetic stimulation and recording of fluorescence signals representing neural activity in up to 7 brain regions of a mouse in vivo. At the same time, we performed optogenetic stimulation in the SNc/VTA brain region of 3 mice expressing the ChrimsonR light-sensitive protein, and recorded the fluorescence signal of the corresponding site simultaneously. In addition, our scheme is also suitable for stimulation and simultaneous recording of multiple brain regions in a single mouse, as well as signal recording and regulation in social and other behaviors in multiple mice. Our system and experimental method allow acquisition and analysis of functional information about relevant brain regions in specific behaviors, thus providing important data and theoretical support for further understanding and treatment of related diseases.
Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Xiongjie Fu,Hanhai Zeng,Jikuang Zhao,Guoyang Zhou,Hang Zhou,Jianfeng Zhuang,Chaoran Xu,Jianru Li,Yucong Peng,Yang Cao,Yin Li,Huaijun Chen,Lin Wang,Feng Yan,Gao Chen

DOI: https://doi.org/10.1007/s12975-021-00919-z

2021-01-01

Translational Stroke Research

Abstract:Correction to this paper has been published: https://doi.org/10.1007/s12975-021-00919-z
Correction to: Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain

Xu-Hui Li,Qi-Yu Chen,Min Zhuo

DOI: https://doi.org/10.1007/s13311-021-01065-y

IF: 6.088

2021-06-04

Neurotherapeutics

Abstract:<p class="a-plus-plus">A correction to this paper has been published: https://doi.org/10.1007/s13311-021-01065-y</p>

pharmacology & pharmacy,neurosciences,clinical neurology
Novel regulatory systems for acetylcholine release in rat striatum and anti‐Alzheimer's disease drugs

Ikunobu Muramatsu,Junsuke Uwada,Hatsumi Yoshiki,Kiyonao Sada,Kung‐Shing Lee,Takashi Yazawa,Takanobu Taniguchi,Matomo Nishio,Takaharu Ishibashi,Takayoshi Masuoka

DOI: https://doi.org/10.1111/jnc.14701

2019-05-07

Journal of Neurochemistry

Abstract:Regulation of neurotransmitter release in the central nervous system is complex. Here, we investigated regulatory mechanisms for acetylcholine (ACh) release from cholinergic neurons by performing superfusion experiments with rat striatal segments after labelling the cellular ACh pool with [3 H]choline. Electrical stimulation-evoked pronounced [3 H]ACh release from cholinergic neurons. The estimated quantity of [3 H]ACh release per pulse of electrical stimulation was reduced by an increase in stimulus frequency, showing an inverse correlation between release probability of ACh and neuronal excitation. ACh release was also negatively regulated by pre-synaptic muscarinic ACh receptors (mAChRs). The autoinhibition induced by released ACh was predominantly suppressed by the M2 -selective antagonist AF-DX 116, partially inhibited by M3 -selective darifenacin, and minimally by M4 -selective PD 102807. Other subtype-selective antagonists had no effect at subtype-selective concentrations. ACh esterase (AChE) inhibitors (diisopropylfluorophosphate, donepezil and galantamine) at concentrations that mostly inhibit esterase activity reduced [3 H]ACh release, and the reduction was abolished by treatment with atropine. This implies that pre-synaptic autoreceptors are activated more after blockade of ACh hydrolysis, leading to autoinhibition of ACh release and consequent reduction in synaptic ACh concentrations. [3 H]efflux was also enhanced by ACh uptake inhibitors (100 μM hemicholinium-3 and physostigmine), regardless of ACh hydrolysis. This study shows that synaptic ACh concentrations in striatal cholinergic neurons are regulated in a complex manner by many factors such as release probability, pre-synaptic M2 /M3 /M4 mAChRs, AChE and post-synaptic ACh uptake, and provides important information about cholinergic neurotransmission for future exploration of therapeutic strategies for Alzheimer's and other central nervous system diseases. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/openscience-badges/.

biochemistry & molecular biology,neurosciences
Author Correction: Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization

Jie Chao,Yuan Zhang,Longfei Du,Rongbin Zhou,Xiaodong Wu,Kai Shen,Honghong Yao

DOI: https://doi.org/10.1038/s41598-021-82645-y

IF: 4.6

2021-03-11

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson’s Disease Models

Asami Tanimura,Yijuan Du,Jyothisri Kondapalli,David L. Wokosin,D. James Surmeier

DOI: https://doi.org/10.1016/j.neuron.2018.12.004

IF: 16.2

2019-02-01

Neuron

Abstract:The motor symptoms of Parkinson's disease (PD) are thought to stem from an imbalance in the activity of striatal direct- and indirect-pathway spiny projection neurons (SPNs). Disease-induced alterations in the activity of networks controlling SPNs could contribute to this imbalance. One of these networks is anchored by the parafascicular nucleus (PFn) of the thalamus. To determine the role of the PFn in striatal PD pathophysiology, optogenetic, chemogenetic, and electrophysiological tools were used in ex vivo slices from transgenic mice with region-specific Cre recombinase expression. These studies revealed that in parkinsonian mice, the functional connectivity of PFn neurons with indirect pathway SPNs (iSPNs) was selectively enhanced by cholinergic interneurons acting through presynaptic nicotinic acetylcholine receptors (nAChRs) on PFn terminals. Attenuating this network adaptation by chemogenetic or genetic strategies alleviated motor-learning deficits in parkinsonian mice, pointing to a potential new therapeutic strategy for PD patients.

neurosciences
Correction: Chen Et Al. the Chemerin/CMKLR1 Axis is Involved in the Recruitment of Microglia to Aβ Deposition Through P38 MAPK Pathway. Int. J. Mol. Sci. 2022, 23, 9041

Yanqing Chen,Zhen Liu,Ping Gong,Haibo Zhang,Yijun Chen,Songquan Yao,Wei Li,Yan Zhang,Yang Yu

DOI: https://doi.org/10.3390/ijms24010506

IF: 5.6

2022-01-01

International Journal of Molecular Sciences

Abstract:In the original publication [...].
Temporal Components of Cholinergic Terminal to Dopaminergic Terminal Transmission in Dorsal Striatum Slices of Mice

Li Wang,Xiaoyu Zhang,Huadong Xu,Li Zhou,Ruiying Jiao,Wei Liu,Feipeng Zhu,Xinjiang Kang,Bin Liu,Sasa Teng,Qihui Wu,Mingli Li,Haiqiang Dou,Panli Zuo,Changhe Wang,Shirong Wang,Zhuan Zhou

DOI: https://doi.org/10.1113/jphysiol.2014.271825

2014-01-01

The Journal of Physiology

Abstract:Key points The timing of synaptic transmission is critical to synaptic plasticity in the striatum. However, the timing of striatal dopamine (DA) release induced by cholinergic interneurons (ChIs) in the striatum is unclear. In this study, we focused on the temporal components of DA release and replenishment triggered by different pathways. We show that stimulation of ChIs induces DA release with a total delay of 20.6 ms, including 2.8 ms for action potential firing of ChIs, 7.0 ms for cholinergic transmission between acetylcholine terminals and DA terminals, and 10.8 ms for downstream DA release. The delay of DA release via this ChI pathway is 1.9 times that via the nigrostriatal pathways. We describe the time course of recovery of DA release via the two pathways and that of vesicle replenishment in DA terminals. Our work provides an example of unravelling the temporal building blocks during fundamental synaptic terminal–terminal transmission. AbstractStriatal dopamine (DA) is critically involved in major brain functions such as motor control and deficits such as Parkinson's disease. DA is released following stimulation by two pathways: the nigrostriatal pathway and the cholinergic interneuron (ChI) pathway. The timing of synaptic transmission is critical in striatal circuits, because millisecond latency changes can reverse synaptic plasticity from long‐term potentiation to long‐term depression in a DA‐dependent manner. Here, we determined the temporal components of ChI‐driven DA release in striatal slices from optogenetic ChAT‐ChR2‐EYFP mice. After a light stimulus at room temperature, ChIs fired an action potential with a delay of 2.8 ms. The subsequent DA release mediated by nicotinic acetylcholine (ACh) receptors had a total latency of 17.8 ms, comprising 7.0 ms for cholinergic transmission and 10.8 ms for the downstream terminal DA release. Similar latencies of DA release were also found in striatal slices from wild‐type mice. The latency of ChI‐driven DA release was regulated by inhibiting the presynaptic vesicular ACh release. Moreover, we describe the time course of recovery of DA release via the two pathways and that of vesicle replenishment in DA terminals. Our work provides an example of unravelling the temporal building blocks during fundamental synaptic terminal–terminal transmission in motor regulation.
Molecularly defined and functionally distinct cholinergic subnetworks

Xinyan Li,Hongyan Yu,Bing Zhang,Lanfang Li,Wenting Chen,Quntao Yu,Xian Huang,Xiao Ke,Yunyun Wang,Wei Jing,Huiyun Du,Hao Li,Tongmei Zhang,Liang Liu,Ling-Qiang Zhu,Youming Lu

DOI: https://doi.org/10.1016/j.neuron.2022.08.025

IF: 16.2

2022-11-17

Neuron

Abstract:Cholinergic neurons in the medial septum (MS) constitute a major source of cholinergic input to the forebrain and modulate diverse functions, including sensory processing, memory, and attention. Most studies to date have treated cholinergic neurons as a single population; as such, the organizational principles underling their functional diversity remain unknown. Here, we identified two subsets (D28K + versus D28K − ) of cholinergic neurons that are topographically segregated in mice, Macaca fascicularis , and humans. These cholinergic subpopulations possess unique electrophysiological signatures, express mutually exclusive marker genes ( kcnh1 and aifm3 versus cacna1h and gga3 ), and make differential connections with physiologically distinct neuronal classes in the hippocampus to form two structurally defined and functionally distinct circuits. Gain- and loss-of-function studies on these circuits revealed their differential roles in modulation of anxiety-like behavior and spatial memory. These results provide a molecular and circuitry-based theory for how cholinergic neurons contribute to their diverse behavioral functions.

neurosciences
Advances in the study of cholinergic circuits in the central nervous system

Ganghua He,Yang Li,Hua Deng,Hongyan Zuo

DOI: https://doi.org/10.1002/acn3.51920

Abstract:Objective: Further understanding of the function and regulatory mechanism of cholinergic neural circuits and related neurodegenerative diseases. Methods: This review summarized the research progress of the central cholinergic nervous system, especially for the cholinergic circuit of the medial septal nucleus-hippocampus, vertical branch of diagonal band-hippocampus, basal nucleus of Meynert-cerebral cortex cholinergic loop, amygdala, pedunculopontine nucleus, and striatum-related cholinergic loops. Results: The extensive and complex fiber projection of cholinergic neurons form the cholinergic neural circuits, which regulate several nuclei in the brain through neurotransmission and participate in learning and memory, attention, emotion, movement, etc. The loss of cholinergic neurotransmitters, the reduction, loss, and degeneration of cholinergic neurons or abnormal theta oscillations and cholinergic neural circuits can induce cognitive disorders such as AD, PD, PDD, and DLB. Interpretation: The projection and function of cholinergic fibers in some nuclei and the precise regulatory mechanisms of cholinergic neural circuits in the brain remain unclear. Further investigation of cholinergic fiber projections in various brain regions and the underlying mechanisms of the neural circuits are expected to open up new avenues for the prevention and treatment of senile neurodegenerative diseases.
Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Hao Qian,Xinjiang Kang,Jing Hu,Dongyang Zhang,Zhengyu Liang,Fan Meng,Xuan Zhang,Yuanchao Xue,Roy Maimon,Steven F. Dowdy,Neal K. Devaraj,Zhuan Zhou,William C. Mobley,Don W. Cleveland,Xiang-Dong Fu

DOI: https://doi.org/10.1038/s41586-020-2583-3

IF: 64.8

2020-07-29

Nature

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Nanoscopic Visualization of Restricted Nonvolume Cholinergic and Monoaminergic Transmission with Genetically Encoded Sensors.

Paula K. Zhu,W. Sharon Zheng,Peng Zhang,Miao Jing,Philip M. Borden,Farhan Ali,Kaiming Guo,Jiesi Feng,Jonathan S. Marvin,Yali Wang,Jinxia Wan,Li Gan,Alex C. Kwan,Li Lin,Loren L. Looger,Yulong Li,Yajun Zhang

DOI: https://doi.org/10.1021/acs.nanolett.9b04877

IF: 10.8

2020-01-01

Nano Letters

Abstract:How neuromodulatory transmitters diffuse into the extracellular space remains an unsolved fundamental biological question, despite wide acceptance of the volume transmission model. Here, we report development of a method combining genetically encoded fluorescent sensors with high-resolution imaging and analysis algorithms which permits the first direct visualization of neuromodulatory transmitter diffusion at various neuronal and non-neuronal cells. Our analysis reveals that acetylcholine and monoamines diffuse at individual release sites with a spread length constant of ∼0.75 μm. These transmitters employ varied numbers of release sites, and when spatially close-packed release sites coactivate they can spillover into larger subcellular areas. Our data indicate spatially restricted (i.e., nonvolume) neuromodulatory transmission to be a prominent intercellular communication mode, reshaping current thinking of control and precision of neuromodulation crucial for understanding behaviors and diseases.
Author Correction: Structure of human GABAB receptor in an inactive state

Jinseo Park,Ziao Fu,Aurel Frangaj,Jonathan Liu,Lidia Mosyak,Tong Shen,Vesna N. Slavkovich,Kimberly M. Ray,Jaume Taura,Baohua Cao,Yong Geng,Hao Zuo,Yongjun Kou,Robert Grassucci,Shaoxia Chen,Zheng Liu,Xin Lin,Justin P. Williams,William J. Rice,Edward T. Eng,Rick K. Huang,Rajesh K. Soni,Brian Kloss,Zhiheng Yu,Jonathan A. Javitch,Wayne A. Hendrickson,Paul A. Slesinger,Matthias Quick,Joseph Graziano,Hongtao Yu,Oliver Fiehn,Oliver B. Clarke,Joachim Frank,Qing R. Fan

DOI: https://doi.org/10.1038/s41586-020-2543-y

IF: 64.8

2020-07-15

Nature

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease

Kushagra Nagori,Madhulika Pradhan,Mukesh Sharma,Ajazuddin,Hemant R Badwaik,Kartik T Nakhate,Hemant R. Badwaik,Kartik T. Nakhate

DOI: https://doi.org/10.2174/0115672050306008240321034006

2024-03-25

Current Alzheimer Research

Abstract:Abstract: Acetylcholine (ACh) is ubiquitously present in the nervous system and has been involved in the regulation of various brain functions. By modulating synaptic transmission and promoting synaptic plasticity, particularly in the hippocampus and cortex, ACh plays a pivotal role in the regulation of learning and memory. These procognitive actions of ACh are mediated by the neuronal muscarinic and nicotinic cholinergic receptors. The impairment of cholinergic transmission leads to cognitive decline associated with aging and dementia. Therefore, the cholinergic system has been of prime focus when concerned with Alzheimer’s disease (AD), the most common cause of dementia. In AD, the extensive destruction of cholinergic neurons occurs by amyloid-β plaques and tau protein-rich neurofibrillary tangles. Amyloid-β also blocks cholinergic receptors and obstructs neuronal signaling. This makes the central cholinergic system an important target for the development of drugs for AD. In fact, centrally acting cholinesterase inhibitors like donepezil and rivastigmine are approved for the treatment of AD, although the outcome is not satisfactory. Therefore, identification of specific subtypes of cholinergic receptors involved in the pathogenesis of AD is essential to develop future drugs. Also, the identification of endogenous rescue mechanisms to the cholinergic system can pave the way for new drug development. In this article, we discussed the neuroanatomy of the central cholinergic system. Further, various subtypes of muscarinic and nicotinic receptors involved in the cognition and pathophysiology of AD are described in detail. The article also reviewed primary neurotransmitters that regulate cognitive processes by modulating basal forebrain cholinergic projection neurons.

neurosciences,clinical neurology
A Novel Approach to Cholinergic Signaling Modulation: Development and Characterization of ML352, a Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter

Elizabeth Ennis,Jane Wright,James Tarr,Charles Locuson,Corey Hopkins,J Daniels,Craig Lindsley,Randy Blakely

DOI: https://doi.org/10.1096/fasebj.29.1_supplement.932.6

2015-04-01

The FASEB Journal

Abstract:The choline transporter (CHT) is a critical determinant of acetylcholine (ACh) synthesis and signaling. Despite the medicinal uses of anticholinergics, CHT remains a largely unexplored target for such endeavors, with only one competitive inhibitor, hemicholinium‐3 (HC‐3), in common use. Thus, we initiated a high‐throughput screen to expand CHT pharmacology, biasing our search toward agents with allosteric modes action. Our efforts identified 5 novel classes of CHT antagonists, with one class subjected to further chemical diversification to improve potency, selectivity and pharmacokinetics. Among these compounds, ML352, was identified as a potent, noncompetitive inhibitor of CHT activity in both transfected cells and nerve terminal preparations. ML352 exhibits little or no inhibitory activity at the ACh homeostatic enzymes or against many other ion channels, transporters and receptors. DMPK studies revealed a high intravenous plasma clearance, a combination of the oral bioavailability and total brain concentrations indicate ML352 to be a suitable probe for investigations of altered in vivo ACh signaling and behavioral effects in rodents. Our efforts reveal ML352 and its derivatives as the first potent and selective CHT inhibitors developed since the identification of HC‐3 more than 50 years ago, providing a novel platform for the treatment of disorders characterized by excess ACh signaling.

cell biology,biochemistry & molecular biology,biology
Correction: Corrigendum: Opportunities and challenges in modeling human brain disorders in transgenic primates

Charles Jennings,Rogier Landman,Yang Zhou,Jitendra Sharma,Julia Hyman,J Anthony Movshon,Zilong Qiu,Angela Roberts,Anna Wang Roe,Xiaoqin Wang,Huihui Zhou,Liping Wang,Feng Zhang,Robert Desimone,Guoping Feng

DOI: https://doi.org/10.1038/nn0717-1033b

IF: 25

2017-01-01

Nature Neuroscience

Abstract:Nat. Neurosci. 19, 1123–1130 (2016); published online 26 August 2016; corrected after print 29 August 2016 In the version of this article initially published online, the first author's name appears as “Charles Jennings” without middle initial; it has been changed to “Charles G Jennings”. Another author's name appears in the author list as “Angela Roberts,” also without middle initial; it has been changed to “Angela C Roberts.
Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes

Jeffrey Stedehouder,Bradley M Roberts,Shinil Raina,Simon Bossi,Alan King Lun Liu,Natalie M Doig,Kevin McGerty,Peter J Magill,Laura Parkkinen,Stephanie J Cragg

DOI: https://doi.org/10.1101/2024.05.15.594341

2024-05-15

Abstract:Astrocytes are increasingly thought to have underestimated and important roles in modulating neuronal circuits. Astrocytes in striatum can regulate dopamine transmission by governing the extracellular tone of axonal neuromodulators, including GABA and adenosine. However, here we reveal that striatal astrocytes occupy a cell type-specific anatomical and functional relationship with cholinergic interneurons (ChIs), through which they rapidly excite ChIs and govern dopamine release via nicotinic acetylcholine receptors on subsecond timescales. We identify that ChI somata are in unexpectedly close proximity to astrocyte somata, in mouse and human, forming a soma-to-soma satellite-like configuration not typically observed for other striatal neurons. Transient depolarization of astrocytes in mouse striatum reversibly regulated ChI excitability by decreasing extracellular calcium. These findings reveal a privileged satellite astrocyte-interneuron interaction for striatal ChIs operating on subsecond timescales via regulation of extracellular calcium dynamics to shape downstream striatal circuit activity and dopamine signaling.

Neuroscience
Sudden Heart Rate Reduction Upon Optogenetic Release of Acetylcholine From Cardiac Parasympathetic Neurons in Perfused Hearts

Angel Moreno,Kendal Endicott,Matthew Skancke,Mary Kate Dwyer,Jaclyn Brennan,Igor R. Efimov,Gregory Trachiotis,David Mendelowitz,Matthew W. Kay

DOI: https://doi.org/10.3389/fphys.2019.00016

IF: 4

2019-01-28

Frontiers in Physiology

Abstract:The balance of sympathetic and parasympathetic tone provides exquisite control of heart rate and contractility and has also been shown to modulate coronary flow and inflammation. Understanding how autonomic balance is altered by cardiac disease is an active area of research, and developing new ways to control this balance provides insights into disease therapies. However, achieving acute neuron-specific stimulation of autonomic neurons can be difficult in experiments that measure the acute effects of nerve stimulation on the heart. Conventional electrical and pharmacological approaches can be spatially and temporally non-selective. Cell-specific expression of light-activated channels (channelrhodopsin, ChR2) is a powerful approach that enables control of the timing and distribution of cellular stimulation using light. We present such an optogenetic approach where parasympathetic cardiac neurons are selectively photoactivated at high temporal precision to initiate cholinergic-mediated slowing of heart rate. Mice were crossbred to express ChR2 in peripheral cholinergic neurons using Cre-Lox recombination driven by a choline acetyltransferase (ChAT) promoter. Hearts from adult mice were excised, perfused, and the epicardium was illuminated (peak 460-465 nm) to photoactivate ChR2. In one set of studies, hearts were illuminated using a large-field LED light source. In other studies, a micro LED was placed on the right atrium to selectively illuminate the junction of the superior vena cava (SVC) and right atrium. The ECG was acquired before, during, and after tissue illumination to measure changes in heart rate. Upon illumination, hearts exhibited sudden and dramatic reductions in heart rate with restoration of normal heart rate after cessation of illumination. Delays in atrioventricular conduction were also observed. Heart rate reductions at the highest irradiance levels were similar to heart rate reductions caused by application of bethanechol (10 μM) or acetylcholine (800 μM). Atropine (50 nM) completely blocked the effect of ChR2 photoactivation, confirming cholinergic mediation. Optogenetic activation of intrinsic parasympathetic neurons reduced heart rate in an immediate, dose-dependent fashion, resembling the slowing of sinus rate in response to acetylcholine. Our results demonstrate a new approach for controlling parasympathetic modulation of cardiac function by selectively activating the endogenous release of acetylcholine from intrinsic cardiac cholinergic neurons. Key Message: Optogenetic photoactivation of intrinsic cardiac neurons provides immediate, tissue-specific stimulation with minimal cross-reactivity. Our results demonstrate that selective expression of channelrhodopsin within cardiac cholinergic neurons enables photoactivated release of acetylcholine, thereby instantaneously slowing sinus rate and altering atrioventricular conduction. This provides for in-depth examination of the endogenous interplay between cardiac autonomic neurons and the functional outcomes of downstream post-synaptic receptor activation.

physiology

Rapid Multi-Directed Cholinergic Transmission in the Central Nervous System

Rapid ‘multi-directed’ cholinergic transmission at central synapses

A Cholinergic Model Synapse to Elucidate Protein Function at Presynatic Terminals

Multichannel Fiber-Based Simultaneous Neural Stimulation and Signal Readout in Vivo

Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Correction to: Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain

Novel regulatory systems for acetylcholine release in rat striatum and anti‐Alzheimer's disease drugs

Author Correction: Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization

Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson’s Disease Models

Correction: Chen Et Al. the Chemerin/CMKLR1 Axis is Involved in the Recruitment of Microglia to Aβ Deposition Through P38 MAPK Pathway. Int. J. Mol. Sci. 2022, 23, 9041

Temporal Components of Cholinergic Terminal to Dopaminergic Terminal Transmission in Dorsal Striatum Slices of Mice

Molecularly defined and functionally distinct cholinergic subnetworks

Advances in the study of cholinergic circuits in the central nervous system

Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Nanoscopic Visualization of Restricted Nonvolume Cholinergic and Monoaminergic Transmission with Genetically Encoded Sensors.

Author Correction: Structure of human GABAB receptor in an inactive state

Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease

A Novel Approach to Cholinergic Signaling Modulation: Development and Characterization of ML352, a Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter

Correction: Corrigendum: Opportunities and challenges in modeling human brain disorders in transgenic primates

Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes

Sudden Heart Rate Reduction Upon Optogenetic Release of Acetylcholine From Cardiac Parasympathetic Neurons in Perfused Hearts